Gliclazide MR
Gliclazide MR is an oral medication used primarily for managing blood sugar levels in individuals with type 2 diabetes. As a modified-release formulation, it ensures a steady release of the active ingredient, providing consistent glucose control throughout the day. Gliclazide belongs to the class of drugs known as sulfonylureas, which work by stimulating the pancreas to release insulin. This medication is particularly beneficial for patients who require a reliable option for maintaining their glycemic index. Regular intake of Gliclazide MR can help prevent long-term diabetic complications by keeping blood sugar levels within the target range. It's an effective choice for those seeking a comprehensive approach to diabetes care.Active substance:
GliclazidePharmachologic effect:
Gliclazide is a sulfonylurea class hypoglycemic agent that stimulates insulin secretion from the beta cells of the pancreas. It helps in controlling blood sugar levels in patients with type 2 diabetes mellitus.Indications:
- Type 2 diabetes mellitus when diet, exercise, and weight loss alone do not result in adequate glycemic control.
Contraindications:
- Hypersensitivity to gliclazide or any of the excipients
- Type 1 diabetes mellitus
- Diabetic ketoacidosis
- Diabetic pre-coma and coma
- Severe renal or hepatic insufficiency
- Treatment with miconazole
- Pregnancy and lactation
Side effects:
In order of decreasing probability: Hypoglycemia, Nausea, Vomiting, Abdominal pain, Diarrhea, Constipation, Dizziness, Headache, Rash, Pruritus
Dosing and Administration:
The usual starting dose is 30 mg once daily. The dose may be adjusted based on the patient's response, with a maximum recommended dose of 120 mg per day. It is advised to take the medication with breakfast.
Storage:
Store at a temperature not exceeding 25°C (77°F).
Gliclazide MR
in Cyrillic : Гликлазид МВ
SUBSTANCE
Gliclazide
DOSAGE FORM
tablets
MANUFACTURER
In Stock
available pack options :
| 30mg x 60 tablets | $8.50 | |
| 60mg x 30 tablets | $8.80 |
